Analysis of Baseline Serum Lipid Profile for Predicting Clinical Outcomes of Patients with Extensive-Stage Small Cell Lung Cancer

References

• Lee J-H, Saxena A, Giaccone G. Advancements in small cell lung cancer. Semin Cancer Biol. 2023;93:123–128. doi:10.1016/j.semcancer.2023.05.008
   PubMed Web of Science ®Google Scholar
• L-L L, C-F Y, Xie H-T, et al. Biomarkers and factors in small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Cancer Med. 2023;12(10):11211–11233. doi:10.1002/cam4.5800
   PubMed Web of Science ®Google Scholar
• Lin G, Yao Z, Kang K, Wang H, Luo R, Lu Y. Efficacy and toxicity profile of first-line treatment for extensive-stage small cell lung cancer: a bayesian network meta-analysis. Cancer Med. 2023;12(9):10230–10242. doi:10.1002/cam4.5750
   PubMed Web of Science ®Google Scholar
• Cani M, Napoli VM, Garbo E, et al. Targeted therapies in small cell lung cancer: from old failures to novel therapeutic strategies. Int J Mol Sci. 2023;24(10):8883. doi:10.3390/ijms24108883
   PubMed Web of Science ®Google Scholar
• Demedts IK, Vermaelen KY, van Meerbeeck JP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J. 2010;35(1):202–215. doi:10.1183/09031936.00105009
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang M, Su J, et al. Lipid metabolism and cancer. Life. 2022;12(6):784. doi:10.3390/life12060784
   PubMedGoogle Scholar
• Li Y, Shang C, Liang H, Zhang K, Wu Y, Guo H. Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis. Front Oncol. 2023;13:1052760. doi:10.3389/fonc.2023.1052760
   PubMed Web of Science ®Google Scholar
• Bai S, Wang H, Shao R, et al. Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia. Front Oncol. 2023;13:950732. doi:10.3389/fonc.2023.950732
   PubMed Web of Science ®Google Scholar
• Pope ED 3rd, Kimbrough EO, Vemireddy LP, Surapaneni PK, Copland JA 3rd, Mody K. Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opin Ther Targets. 2019;23:473–483. doi:10.1080/14728222.2019.1615883
   PubMed Web of Science ®Google Scholar
• Van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741–1755. doi:10.1016/S0140-6736(11)60165-7
   PubMed Web of Science ®Google Scholar
• Hendriks LEL, Menis J, Reck M. Prospects of targeted and immune therapies in SCLC. Expert Rev Anticancer Ther. 2019;19(2):151–167. doi:10.1080/14737140.2019.1559057
   PubMed Web of Science ®Google Scholar
• Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021;218(1):e20201606. doi:10.1084/jem.20201606
   PubMed Web of Science ®Google Scholar
• Tang X, Brindley DN. Lipid phosphate phosphatases and cancer. Biomolecules. 2020;10(9):1263. doi:10.3390/biom10091263
   PubMed Web of Science ®Google Scholar
• Chen Q, Tang F, Zhang H. Significance of the expression of TC and TG levels in the initial diagnosis and treatment of SCLC patients and their tie-in with prognosis. Contrast Media Mol Imaging. 2022;5:2022.
   Google Scholar
• Xu H, Zhou S, Tang Q, Xia H, Bi F. Cholesterol metabolism: new functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874(1):188394. doi:10.1016/j.bbcan.2020.188394
   PubMed Web of Science ®Google Scholar
• YuPeng L, YuXue Z, PengFei L, et al. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1086–1093. doi:10.1158/1055-9965.EPI-14-1329
   PubMed Web of Science ®Google Scholar
• Na C, Wang X, Guo J, Liu P. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study. Lipids Health Dis. 2021;20(1):69. doi:10.1186/s12944-021-01492-y
   PubMed Web of Science ®Google Scholar
• Wen Y, Wang G, Chen HD, et al. Total cholesterol and the risk of primary liver cancer in Chinese males: a prospective cohort study. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54(7):753–759. doi:10.3760/cma.j.cn112150-20190809-00646
   PubMedGoogle Scholar
• Kitson SJ, Lindsay J, Sivalingam VN, et al. The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study. Gynecol Oncol. 2018;148(1):154–160. doi:10.1016/j.ygyno.2017.11.019
   PubMed Web of Science ®Google Scholar
• Bobin-Dubigeon C, Nazih H, Blanchard V, Croyal M, Bard JM. Circulating HDL and non-HDL associated apolipoproteins and breast cancer severity. J Clin Med. 2022;11(5):1345. doi:10.3390/jcm11051345
   PubMed Web of Science ®Google Scholar
• Fan Y, Ding X, Wang J, et al. Decreased serum HDL at initial diagnosis correlates with worse outcomes for triple-negative breast cancer but not non-TNBCs. Int J Biol Markers. 2015;30(2):e200–e207. doi:10.5301/jbm.5000143
   PubMed Web of Science ®Google Scholar
• Yang Y, Mauldin PD, Ebeling M, et al. Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer. 2013;119(8):1512–1520. doi:10.1002/cncr.27923
   PubMed Web of Science ®Google Scholar
• Onwuka JU, Okekunle AP, Olutola OM, et al. Lipid profile and risk of ovarian tumours: a meta-analysis. BMC Cancer. 2020;20(1):200. doi:10.1186/s12885-020-6679-9
   PubMed Web of Science ®Google Scholar
• Pirro M, Ricciuti B, Rader DJ, Catapano AL, Sahebkar A, Banach M. High density lipoprotein cholesterol and cancer: marker or causative? Prog Lipid Res. 2018;71:54–69. doi:10.1016/j.plipres.2018.06.001
   PubMed Web of Science ®Google Scholar
• Ganjali S, Banach M, Pirro M, Fras Z, Sahebkar A. HDL and cancer - causality still needs to be confirmed? Update 2020. Semin Cancer Biol. 2021;73:169–177. doi:10.1016/j.semcancer.2020.10.007
   PubMed Web of Science ®Google Scholar
• Dai D, Chen B, Wang B, et al. Pretreatment TG/HDL-C ratio is superior to triacylglycerol level as an independent prognostic factor for the survival of triple negative breast cancer patients. J Cancer. 2016;7(12):1747–1754. doi:10.7150/jca.15776
   PubMed Web of Science ®Google Scholar
• Hu D, Peng F, Lin X, et al. Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (Fiesta) study. BMC Cancer. 2018;18(1):785. doi:10.1186/s12885-018-4596-y
   PubMedGoogle Scholar
• Huang D, Zheng S, Huang F, et al. Prognostic nomograms integrating preoperative serum lipid derivative and systemic inflammatory marker of patients with non-metastatic colorectal cancer undergoing curative resection. Front Oncol. 2023;13:1100820. doi:10.3389/fonc.2023.1100820
   PubMed Web of Science ®Google Scholar
• Tcheng M, Roma A, Ahmed N, et al. Very long chain fatty acid metabolism is required in acute myeloid leukemia. Blood. 2021;137(25):3518–3532. doi:10.1182/blood.2020008551
   PubMed Web of Science ®Google Scholar
• Zhang X, Ma L, Hao Y, Zuo X, Cheng Y. P112 significance of low expression of tumor associated Gene ki67 in recurrence of small cell lung cancer. J Thorac Oncol. 2018;12(12):S1089. doi:10.1016/j.jtho.2018.10.138
   Google Scholar
• Yao X, Wang T, Yang Sun M, Yuming Y, Guixin D, Liu J. Diagnostic value of lncRNA HOTAIR as a biomarker for detecting and staging of non-small cell lung cancer. Biomarkers. 2022;27(6):526–533. doi:10.1080/1354750X.2022.2085799
   PubMed Web of Science ®Google Scholar